Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.666, 2012-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Current PCV-7 vaccination not cost effective in the Netherlands
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 606, 2010-01 ,pp. :
Access to resources
Recommend
PCV13 spells cost savings in several settings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 656, 2012-01 ,pp. :
Adult vaccination with PCV13 worth a shot in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 652, 2012-01 ,pp. :
PHiD-CV dominates PCV-13 in Sweden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 647, 2012-01 ,pp. :
Universal PCV13 proves its worth in Taiwan
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 648, 2012-01 ,pp. :